Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 5/2024

Inhalt (60 Artikel)

Open Access Review

Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors

Yan Kang, Huiting Li, Yiping Liu, Zheng Li

Open Access Research

Dynamic change in the peritoneal cancer index based on CT after chemotherapy in the overall survival prediction of gastric cancer patients with peritoneal metastasis

Yi-Yuan Wei, Jie-Yuan Cai, Lin-Lin Wang, Jie Yang, Yan-Ling Li, Xiao-Ting Li, Xiao-Tian Zhang, Yan-Jie Shi, Lei Tang

Open Access Research

Predicting response of hepatoblastoma primary lesions to neoadjuvant chemotherapy through contrast-enhanced computed tomography radiomics

Yanlin Yang, Haoru Wang, Jiajun Si, Li Zhang, Hao Ding, Fang Wang, Ling He, Xin Chen

Open Access Research

Effective bridging strategies prior to infusion with tisagenlecleucel results in high response rates and long-term remission in relapsed/refractory large B-cell lymphoma: findings from a German monocentric study

Farina Eigendorff, Irina Filimonova, Sebastian Scholl, Anne Sayer-Klink, Silke Rummler, Christa Kunert, Klaus Pietschmann, Andrea Wittig, Andreas Hochhaus, Ulf Schnetzke

Open Access Research

Primary lung cancer in children and adolescents

Qiuming Chen, Jun Cheng, Luming Wang, Xiayi Lv, Jian Hu

Open Access Matters Arising

A perspective on tumor radiation resistance following high-LET radiation treatment

Yogendra Singh Rajpurohit, Dhirendra Kumar Sharma, Mitu Lal, Ishu Soni

Open Access Case Based Report

Germline findings in cancer predisposing genes from a small cohort of chordoma patients

Margarita Raygada, Liny John, Anne Liu, Julianne Schultz, B. J. Thomas, Donna Bernstein, Markku Miettinen, Mark Raffeld, Liqiang Xi, Manoj Tyagi, Kenneth Aldape, John Glod, Karlyne M. Reilly, Brigitte C. Widemann, Mary Frances Wedekind

Open Access Research

Knockdown of NADK promotes LUAD ferroptosis via NADPH/FSP1 axis

Xiangpeng Meng, Fang Peng, Shijie Yu, Xinming Chi, Wenchi Wang, Shujuan Shao

Open Access Correspondence

Cancer of unknown primary derived from regressed breast cancer

Maria Pouyiourou, Theresa Mokry, Maximilian Feszler, Andrea Teifke, Andreas Kreft, Alwin Krämer

Open Access Research

LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K/Akt signaling pathway

Lulu Cheng, Xiaofei Li, Wenhui Dong, Jing Yang, Pengmei Li, Xihui Qiang, Jiajun Yin, Lianyi Guo

Open Access Research

Targeting BMAL1 reverses drug resistance of acute myeloid leukemia cells and promotes ferroptosis through HMGB1-GPX4 signaling pathway

Hong Zheng, Ting Wu, Zhi Lin, Dan Wang, Jing Zhang, Ting Zeng, Leping Liu, Jie Shen, Mingyi Zhao, Jia-Da Li, Minghua Yang

Open Access Research

Modified Lichong decoction intervenes in colorectal cancer by modulating the intestinal flora and the Wnt/β-catenin signaling pathway

Longhui Liu, Mengmeng Zhao, Xiaomeng Lang, Sujie Jia, Xin Kang, Yue Liu, Jianping Liu

Open Access Research

Safety, efficacy, and survival of different transarterial chemoembolization techniques in the management of unresectable hepatocellular carcinoma: a comparative single-center analysis

Philipp Schindler, Daniel Kaldewey, Florian Rennebaum, Jonel Trebicka, Andreas Pascher, Moritz Wildgruber, Michael Köhler, Max Masthoff

Open Access Review

The role of tumor-associated macrophages in tumor immune evasion

Ruizhe Huang, Ting Kang, Siyu Chen

Open Access Research

KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway

Meng Zhai, Jiyu Miao, Ru Zhang, Rui Liu, Fangmei Li, Ying Shen, Ting Wang, Xuezhu Xu, Gongzhizi Gao, Jinsong Hu, Aili He, Ju Bai

Open Access Research

Identification of immunogenic cell death-related damage-related molecular patterns (DAMPs) to predict outcomes in patients with head and neck squamous cell carcinoma

Jiayi Zhang, Xinzhan Shi, Mengqi Wang, Rundong Zhai, Mengyao Wang, Zizhen Gong, Zihui Ni, Teng Xu, Weiwen Zhu, Laikui Liu

Open Access Research

GALAD score as a prognostic model for recurrence of hepatocellular carcinoma after local ablation

Wenying Qiao, Jiashuo Li, Yiqi Xiong, Jiasheng Zheng, Ronghua Jin, Caixia Hu

Open Access Research

LAMP2A regulates cisplatin resistance in colorectal cancer through mediating autophagy

Zhiliang Shi, Shuting Yang, Chenglong Shen, Jiazhe Shao, Fang Zhou, Haichen Liu, Guoqiang Zhou

Open Access Research

Cystatin SA attenuates gastric cancer cells growth and increases sensitivity to oxaliplatin via PI3K/AKT signaling pathway

Yida Lu, Huizhen Wang, Sihan Chen, Bo Yang, Yaxian Li, Yongxiang Li

Open Access Research

RRP8, associated with immune infiltration, is a prospective therapeutic target in hepatocellular carcinoma

Kai You, Xingxing Du, Yunzheng Zhao, Fukai Wen, Zhaoyang Lu, Huitao Fan

Open Access Research

Endoscopic submucosal dissection versus surgery for T1b esophageal carcinoma: a single-center retrospective study

Ting Zhang, Hanying Wang, Tian Jin, Zeyu Wu, Xiuqing Li, Qide Zhang

Open Access Review

Psychosocial factors associated with quality of life in cancer survivors: umbrella review

Viktorya Voskanyan, Chiara Marzorati, Diana Sala, Roberto Grasso, Ricardo Pietrobon, Iris van der Heijden, Merel Engelaar, Nanne Bos, Augusto Caraceni, Norbert Couspel, Montse Ferrer, Mogens Groenvold, Stein Kaasa, Claudio Lombardo, Aude Sirven, Hugo Vachon, Galina Velikova, Cinzia Brunelli, Giovanni Apolone, Gabriella Pravettoni

Open Access Research

Implementation of quality indicators for vulvar cancer in gynaecological cancer centres certified by the German Cancer Society (DKG)

Frederik A. Stuebs, Matthias W. Beckmann, Christian Dannecker, Markus Follmann, Monika Nothacker, Hans-Georg Schnürch, Linn Woelber, Simone Wesselmann

Open Access Research

FIGO 2023 endometrial staging: a leap of faith into the new “prognostic based’ rather than “anatomical based” staging—too fast too furious??

Karthik Chandra Bassetty, Dimpy Begum, Debabrata Barmon, Upasana Baruah, Sakshi Gupta, Mahendra Kumar, Jyotiman Nath, Duncan Khanikar, Mouchumee Bhattacharyya, P. S. Roy

Open Access Research

Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors’ perspective

Katharina C. Kähler, Ralf Gutzmer, Yenny Angela, Elisabeth Livingstone, Georg Lodde, Frank Meiss, David A. Rafei-Shamsabadi, Sera S. Weyer-Fahlbusch, Dorothée Nashan, Carmen Loquai, Jessica C. Hassel, Michael M. M. Sachse, Lara V. Maul, Lucie Heinzerling, Markus V. Heppt, Chiara Colapietro, Judith Rusch, Christine Blome

Open Access Research

Utilizing a structure-based virtual screening approach to discover potential LSD1 inhibitors

Zhehao Fan, Xiaofeng Liu, Ning Wang, Shiyi Yu, Caili Bi, Yue Si, Xinyue Ling, Chenxu Liu, Jingcheng Wang, Haibo Sun

Open Access Research

A meta-analysis of MRI radiomics-based diagnosis for BI-RADS 4 breast lesions

Jie Lin, Hao Zheng, Qiyu Jia, Jingjing Shi, Shiwei Wang, Junna Wang, Min Ge

Open Access Research

Risk assessment model based on nucleotide metabolism-related genes highlights SLC27A2 as a potential therapeutic target in breast cancer

Bo Zhang, Yunjiao Zhang, Kexin Chang, Niuniu Hou, Pengyu Fan, Cheng Ji, Liuyin Liu, Zhe Wang, Ruolei Li, Yaping Wang, Jian Zhang, Rui Ling

Open Access Review

The emerging role and mechanism of HMGA2 in breast cancer

Qing Ma, Sisi Ye, Hong Liu, Yu Zhao, Wei Zhang

Open Access Research

Survival outcomes of neoadjuvant immunochemotherapy versus chemotherapy for locally advanced esophageal squamous cell carcinoma

Huilai Lv, Fan Zhang, Chao Huang, Shi Xu, Jiachen Li, Bokang Sun, Chunyue Gai, Zhao Liu, Mingbo Wang, Zhenhua Li, Ziqiang Tian

Open Access Research

Genome-wide investigation of lncRNAs revealed their tight association with gastric cancer

Tong Liu, Yuedong Ma, Shuo Han, Pengda Sun

Open Access Research

A novel tRNA-derived fragment tRF-17-18VBY9M works as a potential diagnostic biomarker for gastric cancer

Chunyan Mao, Zhihan Zhang, Ronghua Fang, Wentao Yuan, Yi Wu, Hui Cong

Open Access Research

Machine learning identifies the role of SMAD6 in the prognosis and drug susceptibility in bladder cancer

Ziang Chen, Yuxi Ou, Fangdie Ye, Weijian Li, Haowen Jiang, Shenghua Liu

Open Access Research

Clinical significance of 18F-FDG-PET/CT for detection of incidental pre-malignant and malignant colonic lesions: correlation with colonoscopic and histopathological results

Yingying Zhang, Jiangqin Han, Junpeng Li, Jinming Cao, Yeye Zhou, Shengming Deng, Bin Zhang, Yi Yang

Open Access Case Based Report

Primary Ewing’s sarcoma of the uterine cervix: a case report and review of the literature

Yuhang Xiao, Yong Zhi, Guangxu Cao, Heling Ma, Jinli Gao, Fang Li

Open Access Research

Use superb microvascular imaging to diagnose and predict metastatic cervical lymph nodes in patients with papillary thyroid carcinoma

Ting Huang, Pin-Tong Huang, Zhi-Yan Luo, Ji-Fang Lv, Pei-Le Jin, Tao Zhang, Yu-Lan Zhao, Yong Wang, Yu-Rong Hong

Open Access Research

A novel subtype based on driver methylation–transcription in lung adenocarcinoma

Xin Wang, Zhenyi Xu, Shuang Zhao, Jiali Song, Yipei Yu, Han Yang, Yan Hou

Open Access Review

Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies

Simona Gurzu, Rita Szodorai, Ioan Jung, Laura Banias

Open Access Research

Outcome prediction of SSTR-RADS-3A and SSTR-RADS-3B lesions in patients with neuroendocrine tumors based on 68Ga-DOTATATE PET/MR

Jing Gao, Jinxin Zhou, Chang Liu, Yu Pan, Xiaozhu Lin, Yifan Zhang

Open Access Research

Study on carotid artery stenosis after radiotherapy for nasopharyngeal carcinoma

JunMei Song, Luo Lan, YuQing Lv, YaJing Wen, Min Kang, RenSheng Wang

Open Access Research

Fluorescein-guided surgery in high-grade gliomas: focusing on the eloquent and deep-seated areas

Yao Xiao, Mingrui Li, Xiangyu Wang, Jun Tan, Chaoying Qin, Qing Liu

Open Access Research

Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade

Miriam Mengoni, Andreas Dominik Braun, Mattes Simon Hinnerichs, Anar Aghayev, Thomas Tüting, Alexey Surov

Open Access Research

Nomograms based on ratio indexes to predict severity and prognosis in immune checkpoint inhibitors-related myocarditis: a retrospective analysis

Zhenli Li, Tiezhu Yao, Guang Liu, Zhengkun Guan, Jing Liu, Ling Guo, Jingtao Ma

Open Access Research

Treatment of endometrial cancer from 2000 to 2020 in Germany: a retrospective population based cohort study

Thomas Papathemelis, Olaf Ortmann, Cynthia Kohl, Petra Neuser, Kees Kleihues-van Tol, Monika Klinkhammer-Schalke, Peter Ugocsai, Christina Barbara Walter, Miriam Rottmann, Catherine Real, Christina Justenhoven, Gabriele Robers, Constanze Schneider, Michael Gerken, Andrea Sackmann, Soo-Zin Kim-Wanner

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.